Top Markets
#1 OpenVPP OpenVPP +13,482.11%
#2 BugsCoin BugsCoin +49.49%
#3 GENIUS AI GENIUS AI +48.41%
#4 TAC TAC +36.21%
#5 Solidus Ai Tech Solidus Ai Tech +32.74%
#6 Zerebro Zerebro +30.62%
#7 Avici Avici +24.13%
#8 Swarms Swarms +21.11%
#9 Resolv RLP Resolv RLP +17.21%
#10 SkyAI SkyAI +15.59%
Coin of the day
OpenVPP OpenVPP
Settings
Language
ENGLISH
Currency
USD
Theme
Hikal Limited Hikal Limited

Hikal Limited

HIKAL
Rank in Stocks #10836
Hikal Limited, together with its subsidiaries, manufactures and sells various... Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Share Price
$2.09
Market Cap
$257.37M
Change (1 day)
0.76%
Change (1 year)
-55.56%
Country
IN
Trade Hikal Limited (HIKAL)

Category

Healthcare
P/S ratio for Hikal Limited (HIKAL)
P/S ratio as of April 2026 TTM: 1.33
According to Hikal Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.33. At the end of 2024 the company had a P/S ratio of 1.92.
P/S ratio history for Hikal Limited from 2005 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 1.33 -50.04%
2025 2.66 38.46%
2024 1.92 10.96%
2023 1.73 -32.74%
2022 2.58 148.37%
2021 1.04 81.75%
2020 0.57 -59.58%
2019 1.41 8.25%
2018 1.30 -23.34%
2017 1.70 60.15%
2016 1.06 -20.76%
2015 1.34 43.48%
2014 0.93 -8.40%
2013 1.02 61.32%
2012 0.63 -33.20%
2011 0.95 -16.27%
2010 1.13 161.26%
2009 0.43 -66.69%
2008 1.30 3.63%
2007 1.25 -37.08%
2006 1.99 17.34%
2005 1.70 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
3.71 179.37%
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
2.40 80.71%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
2.00 50.67%
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
5.40 306.37%
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.06 431.39%
IN